FDA Clears Binx Health Point-of-Care Testing Platform for Chlamydia and Gonorrhea

The test — which uses PCR amplification and electrochemical detection — provides sample-to-answer results in about 30 minutes for the detection of chlamydia and gonorrhea, two highly prevalent sexually transmitted infections, the firm said. The platform uses female vaginal swab samples collected by a clinician or self-collected by a patient in a clinical setting.

Sourced through Scoop.it from: www.360dx.com